NCT07200583 2025-11-18
PAIA-Haplo
Fujian Medical University
Completed
Clinical Trials
10 trialsNCT05923879 2023-06-28
Mechanism Investigation of Selinexor Combined With Lenalidomide and Rituximab in the Treatment of Diffuse Large B-cell Lymphoma
Ruijin Hospital
Unknown
NCT05690191 2023-01-19
Chidamide in Patients With Recurrent and Refractory Diffuse Large b
Second Affiliated Hospital of Soochow University
Enrolling by invitation
NCT03545035 2022-05-12
LLC178
Gruppo Italiano Malattie EMatologiche dell'Adulto
Completed
NCT02491398 2020-10-06
LLC1315
Gruppo Italiano Malattie EMatologiche dell'Adulto
Completed
NCT04127916 2020-03-18
Bendamustine Plus Rituximab for Mantle Cell Lymphoma: a Multicenter Retrospective Analysis(BR-MCL)
Samsung Medical Center
Unknown
NCT02732236 2018-04-18
Marginal Zone Lymphoma Cohort in Korea
Dong-A University Hospital
Unknown
NCT01144754 2016-07-01
Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT
Stanford University
Terminated
NCT00301301 2010-01-12
A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Royal Marsden NHS Foundation Trust
Completed
NCT00429065 2007-01-31
Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.
Instituto Nacional de Cancerologia de Mexico
Unknown